Delve Insight Market Research Reports





RSS Sort By :
TITLE Price Buy Now More options

DelveInsight’s, “20s Proteasome Inhibitor-Mechanism of action Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across 20s Proteasome Inhibitor. The report provides a complete understanding of...

$ 1500


DelveInsight’s, “30S Ribosomal Subunit (30S RNA) Inhibitor-Mechanism of action Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across 30S Ribosomal Subunit (30S RNA) Inhibitor. The report pr...

$ 2000


DelveInsight’s, “50S Ribosomal Subunit (50S RNA) Inhibitor-Mechanism of action Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across 50S Ribosomal Subunit (50S RNA) Inhibitor. The report pr...

$ 1500


DelveInsight’s, “5-HT1 Agonist-Mechanism of action Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across 5-HT1 Agonist. The report provides a complete understanding of the pipeline activiti...

$ 2000


DelveInsight’s, “5-HT1 Antagonist-Mechanism of action Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across 5-HT1 Antagonist. The report provides a complete understanding of the pipeline ac...

$ 1500


DelveInsight’s, “5-HT1B Agonist-Mechanism of action Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across 5-HT1B Agonist. The report provides a complete understanding of the pipeline activi...

$ 1500


DelveInsight’s, “5-HT1D Agonist-Mechanism of action Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across 5-HT1D Agonist. The report provides a complete understanding of the pipeline activi...

$ 1500


DelveInsight’s, “5-HT2 Agonist-Mechanism of action Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across 5-HT2 Agonist. The report provides a complete understanding of the pipeline activiti...

$ 1500


DelveInsight’s, “5-HT2 Antagonist-Mechanism of action Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across 5-HT2 Antagonist. The report provides a complete understanding of the pipeline ac...

$ 2000


DelveInsight’s, “5-HT2C Antagonist-Mechanism of action Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across 5-HT2C Antagonist. The report provides a complete understanding of the pipeline ...

$ 1500


DelveInsight’s, “5-HT4 Agonist-Mechanism of action Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across 5-HT4 Agonist. The report provides a complete understanding of the pipeline activiti...

$ 2000


DelveInsight’s, “Acetylcholine Receptor (AChR) Antagonist-Mechanism of action Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Acetylcholine Receptor (AChR) Antagonist. The report prov...

$ 2000


DelveInsight’s, “Adenosine Antagonist-Mechanism of action Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Adenosine Antagonist. The report provides a complete understanding of the pip...

$ 2000


DelveInsight’s, “Adrenergic Antagonist-Mechanism of action Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Adrenergic Antagonist. The report provides a complete understanding of the p...

$ 2000


DelveInsight’s, “Adrenergic Uptake Inhibitor-Mechanism of action Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Adrenergic Uptake Inhibitor. The report provides a complete understand...

$ 2000


DelveInsight’s, “Akt1 Inhibitor-Mechanism of action Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Akt1 Inhibitor. The report provides a complete understanding of the pipeline activi...

$ 2000


DelveInsight’s, “Alpha Receptor Antagonist-Mechanism of action Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Alpha Receptor Antagonist. The report provides a complete understanding ...

$ 2000


DelveInsight’s, “Androgen Antagonist-Mechanism of action Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Androgen Antagonist. The report provides a complete understanding of the pipel...

$ 1500


DelveInsight’s, “Anti-CD274 (PD-L1) Antibody-Mechanism of action Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Anti-CD274 (PD-L1) Antibody. The report provides a complete understand...

$ 1500


DelveInsight’s, “Anti-CD279 (PD-1) Antibody-Mechanism of action Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Anti-CD279 (PD-1) Antibody. The report provides a complete understandin...

$ 1500


DelveInsight’s, “Anti-CD3 Antibody-Mechanism of action Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Anti-CD3 Antibody. The report provides a complete understanding of the pipeline ...

$ 1500

Live Chat Support
Need Help?
Name
Email
Phone
Country
Subject
Comments

Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest from Delve Insight. We have market research reports of all sectors covered by the Delve Insight; you can access and utilize them at economical budgets.

More about our Subscription option